Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease. - Seagle HM; Akerele AT; DeCorte JA; Hellwege JN; Breeyear JH; Kim J; Levin M; Khodurksy S; Bress A; Lee K; Meiler J; Gill D; et al. (MedRxiv : the preprint server for health sciences, 2025)